Current Ratio of Inhibikase Therapeutics, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inhibikase Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Inhibikase Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1296%, a 458% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Inhibikase Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1296% +1064% +458% 30 Sep 2025
Q2 2025 1099% +736% +203% 30 Jun 2025
Q1 2025 983% +492% +100% 31 Mar 2025
Q4 2024 736% +33% +4.7% 31 Dec 2024
Q3 2024 232% -541% -70% 30 Sep 2024
Q2 2024 362% -466% -56% 30 Jun 2024
Q1 2024 491% 31 Mar 2024
Q4 2023 703% 31 Dec 2023
Q3 2023 773% 30 Sep 2023
Q2 2023 829% 30 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.